Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia.

scientific article

Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0002-9378(99)70630-7
P698PubMed publication ID10329891

P50authorMelania AmorimQ77755331
P2093author name stringA Faúndes
L C Santos
P2860cites workAntenatal corticosteroid prescribing: setting standards of careQ40874777
A case report of maternal death associated with betamimetics and betamethasone administration in premature laborQ42241027
Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trialQ46373794
Maternal administration of dexamethasone in severe pregnancy-induced hypertensionQ70578102
Cardiovascular response and complications of glucocorticoid therapy in hypertensive pregnanciesQ71675563
Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal OutcomesQ72414034
Fetal lung maturity is not accelerated in preeclamptic pregnanciesQ72602381
Pregnancy-induced hypertension and hyaline membrane diseaseQ73575162
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectpre-eclampsiaQ61335
maternal healthQ6786626
P304page(s)1283-1288
P577publication date1999-05-01
P1433published inAmerican Journal of Obstetrics and GynecologyQ4744256
P1476titleCorticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia
P478volume180

Reverse relations

cites work (P2860)
Q37542495A conference report on prenatal corticosteroid use in low- and middle-income countries
Q33948316Antecedents of cerebral palsy in very low-birth weight infants
Q26769708Antenatal Corticosteroids for Reducing Adverse Maternal and Child Outcomes in Special Populations of Women at Risk of Imminent Preterm Birth: A Systematic Review and Meta-Analysis
Q96229858Antenatal corticosteroids and preterm offspring outcomes in hypertensive disorders of pregnancy: A Japanese cohort study
Q24245169Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
Q30400140Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
Q34250646Antenatal corticosteroids for fetal lung maturation in threatened preterm delivery: indications and administration
Q46301882Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials
Q38281536Antenatal glucocorticoids: where are we after forty years?
Q54723347Antenatal steroid exposure and outcomes of very premature infants: a regional cohort study.
Q24613198Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth
Q54990701Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.
Q90101191Association of Maternal Preeclampsia with Neonatal Respiratory Distress Syndrome in Very-Low-Birth-Weight Infants
Q34705137Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol
Q30558004Born too soon: care during pregnancy and childbirth to reduce preterm deliveries and improve health outcomes of the preterm baby
Q46351013Criteria of pregnancy termination in women with preeclampsia
Q34785352Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial
Q92697645Evaluation of Maternal Drug Exposure Following the Administration of Antenatal Corticosteroids During Late Pregnancy Using Physiologically-Based Pharmacokinetic Modeling
Q33334624HELLP syndrome
Q46322372Health consequences of prophylactic exposure to antenatal corticosteroids among children born late preterm or term
Q38256857Infants at risk of cerebral palsy: a systematic review of outcomes used in Cochrane studies of pregnancy, childbirth and neonatology.
Q27007059Is inflammation the cause of pre-eclampsia?
Q37709901Judicious use of antenatal glucocorticoids: putting the risks into the balance
Q80948590Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement
Q30234715Outcome reporting across randomised controlled trials evaluating therapeutic interventions for pre-eclampsia: a systematic review
Q38263967Outcomes of expectant management after betamethasone for hypertensive disorders of pregnancy
Q81446389Pre-eclampsia
Q35141777Pre-eclampsia: pathophysiology, diagnosis, and management
Q89319637Respiratory Compliance in Late Preterm Infants (340/7-346/7 Weeks) after Antenatal Steroid Therapy
Q34086090Risks and benefits of therapies for apnoea in premature infants
Q37859881Role of fetal sex in the outcome of antenatal glucocorticoid treatment to prevent respiratory distress syndrome: systematic review and meta-analysis.
Q21261342The HELLP syndrome: clinical issues and management. A Review
Q33990742The detection, investigation and management of hypertension in pregnancy: full consensus statement
Q36131296The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia
Q48146361Treatment using tadalafil for severe pre-eclampsia with fetal growth restriction
Q39107351Use of antenatal corticosteroids in special circumstances: a comprehensive review
Q33198560Use of steroids in the perinatal period.
Q54665570Use or overuse of antenatal corticosteroids for suspected preterm birth.

Search more.